Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 24, 2026 0

The World Health Organization (WHO) has unveiled a suite of groundbreaking recommendations aimed at revolutionizing tuberculosis (TB) diagnostics, emphasizing speed,…

Read More
Stem Cell & Regenerative Medicine

Deciphering the Inflammatory Niche: How Bone Marrow Microenvironments Drive the Progression of Pre-Leukemic States and Age-Related Blood Disorders

Dwi Wanna Apr 24, 2026 0

Every second, the human bone marrow performs a biological feat of staggering proportions, generating millions of fresh blood and immune…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.

Reynand Amr Wu Apr 17, 2026 0

The global landscape of tuberculosis (TB) diagnostics is undergoing a significant transformation following new recommendations issued by the World Health…

Read More
Clinical Diagnostics & Pathology

WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States

Reynand Amr Wu Apr 9, 2026 0

The global fight against tuberculosis (TB) has reached a pivotal juncture, with the World Health Organization (WHO) unveiling transformative new…

Read More
Clinical Diagnostics & Pathology

WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.

Reynand Amr Wu Apr 1, 2026 0

The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…

Read More

Posts pagination

1 2
Johns Hopkins Study Reveals Significant Cardiac Weakening and Molecular Changes in Bioengineered Heart Tissues After Month Long Space Station MissionTop 7 Docker Compose Templates Every Developer Should UseAtomically-Based Computers May Require a Fraction of Previously Estimated QubitsTWiV 1292: Clinical Update with Dr. Daniel Griffin Explores Critical Decline in American Public Health and Global Health Security
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ